Shuichi Okamatsu

433 total citations
28 papers, 338 citations indexed

About

Shuichi Okamatsu is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Shuichi Okamatsu has authored 28 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Shuichi Okamatsu's work include Cardiac Imaging and Diagnostics (8 papers), Acute Myocardial Infarction Research (6 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Shuichi Okamatsu is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Acute Myocardial Infarction Research (6 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Shuichi Okamatsu collaborates with scholars based in Japan, United States and South Africa. Shuichi Okamatsu's co-authors include Allan M. Lefer, Hiroaki Shimokawa, Lefer Am, Hiromasa Araki, Ronald Peck, J. Bryan Smith, Edward F. Smith, Akira Yamada, Tohru Yamawaki and K. Nagasawa and has published in prestigious journals such as European Heart Journal, American Heart Journal and Heart.

In The Last Decade

Shuichi Okamatsu

28 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuichi Okamatsu Japan 11 190 93 79 52 50 28 338
Mitsuhiro Yokota Japan 8 218 1.1× 63 0.7× 108 1.4× 97 1.9× 56 1.1× 11 399
Phillip Apprill United States 8 342 1.8× 146 1.6× 111 1.4× 85 1.6× 74 1.5× 9 499
Ken Kanamasa Japan 12 293 1.5× 107 1.2× 101 1.3× 76 1.5× 26 0.5× 59 435
F Rauscha Austria 10 180 0.9× 41 0.4× 81 1.0× 58 1.1× 40 0.8× 34 350
Lüscher Tf Switzerland 12 253 1.3× 46 0.5× 57 0.7× 115 2.2× 58 1.2× 29 449
Alfonso Antonio Taccardi Italy 11 161 0.8× 47 0.5× 93 1.2× 101 1.9× 101 2.0× 17 435
James M. Schmitz United States 9 212 1.1× 60 0.6× 63 0.8× 33 0.6× 69 1.4× 12 362
Pietro Paolo Campa Italy 12 336 1.8× 214 2.3× 132 1.7× 50 1.0× 87 1.7× 20 652
B Haider United States 14 471 2.5× 152 1.6× 79 1.0× 47 0.9× 114 2.3× 29 633
Norio Fujita Japan 6 175 0.9× 53 0.6× 58 0.7× 87 1.7× 64 1.3× 7 336

Countries citing papers authored by Shuichi Okamatsu

Since Specialization
Citations

This map shows the geographic impact of Shuichi Okamatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuichi Okamatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuichi Okamatsu more than expected).

Fields of papers citing papers by Shuichi Okamatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuichi Okamatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuichi Okamatsu. The network helps show where Shuichi Okamatsu may publish in the future.

Co-authorship network of co-authors of Shuichi Okamatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuichi Okamatsu. A scholar is included among the top collaborators of Shuichi Okamatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuichi Okamatsu. Shuichi Okamatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miura, Yutaka, Yoshihiro Fukumoto, Nobuyuki Shiba, et al.. (2010). Prevalence and Clinical Implication of Metabolic Syndrome in Chronic Heart Failure - Report From MetS-CHF Study -. Circulation Journal. 74(12). 2612–2621. 37 indexed citations
2.
Yamawaki, Tohru, Akira Yamada, Yoshihiro Fukumoto, et al.. (2007). Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.. PubMed. 98(6). 260–9. 5 indexed citations
3.
Kishi, Takuya, Takayuki Uchida, Yoshihiro Ohishi, et al.. (2006). Case of isolated thoracic aortic aneurysm as a manifestation of undiscovered giant cell arteritis.. PubMed. 97(12). 358–65. 2 indexed citations
4.
Oi, Keiji, Hiroaki Shimokawa, Yoji Hirakawa, et al.. (2004). Postprandial Increase in Plasma Concentrations of Remnant-Like Particles: An Independent Risk Factor for Restenosis after Percutaneous Coronary Intervention. Journal of Cardiovascular Pharmacology. 44(1). 66–73. 12 indexed citations
5.
Nagasawa, K., Kenichi Arimura, Kenji Miyata, et al.. (2003). Simultaneous assessment of wall motion and coronary flow velocity in the left anterior descending coronary artery during dipyridamole stress echocardiography. Journal of the American Society of Echocardiography. 16(5). 457–463. 50 indexed citations
6.
Matsui, Kunihiko, Tsuguya Fukui, Kenji Hira, et al.. (2002). Impact of sex and its interaction with age on the management of and outcome for patients with acute myocardial infarction in 4 Japanese hospitals. American Heart Journal. 144(1). 101–107. 17 indexed citations
7.
Matsui, Kunihiko, et al.. (1999). Management of patients with acute myocardial infarction at five academic medical centers: clinical characteristics, resource utilization, and outcome.. PubMed. 47(3). 134–40. 14 indexed citations
8.
Shimokawa, Hiroaki, et al.. (1996). Endothelial Gi Protein Expression Is Markedly Low in Human Coronary Microvessels. Journal of Cardiovascular Pharmacology. 27(2). 297–302. 6 indexed citations
9.
Tsutsui, Masato, et al.. (1996). Effect of Cilostazol, a Novel Anti-Platelet Drug, on Restenosis After Percutaneous Transluminal Coronary Angioplasty. Japanese Circulation Journal. 60(4). 207–215. 12 indexed citations
10.
Shimokawa, Hiroaki, et al.. (1994). Endothelial Gi protein in human coronary arteries. European Heart Journal. 15(9). 1261–1266. 26 indexed citations
11.
Tsutsui, Masato, et al.. (1993). Intracellular Magnesium Deficiency in Acute Myocardial Infarction.. Japanese Heart Journal. 34(4). 391–401. 5 indexed citations
12.
13.
Mohri, Mehrdad, Shuichi Okamatsu, & M. Nakamura. (1988). Biphasic response of coronary arterial diameter to intracoronary ergonovine. Clinical Cardiology. 11(10). 710–714. 5 indexed citations
14.
Okamatsu, Shuichi & Allan M. Lefer. (1983). The protective effects of nifedipine in the isolated cat heart. Journal of Surgical Research. 35(1). 35–40. 3 indexed citations
15.
Okamatsu, Shuichi, et al.. (1982). Protective actions of dexamethasone in acute cerebral ischemia.. PubMed. 9(4). 445–56. 7 indexed citations
16.
Lefer, Allan M., et al.. (1982). Salutary actions of thromboxane synthetase inhibition during global myocardial ischemia. Naunyn-Schmiedeberg s Archives of Pharmacology. 321(2). 130–134. 10 indexed citations
17.
Okamatsu, Shuichi & Allan M. Lefer. (1982). Cardiac effects of prostaglandins during global ischemia in isolated perfused cat hearts. Prostaglandins Leukotrienes and Medicine. 8(1). 1–10. 2 indexed citations
18.
Am, Lefer, Hiromasa Araki, & Shuichi Okamatsu. (1981). Beneficial actions of a free radical scavenger in traumatic shock and myocardial ischemia.. PubMed. 8(3). 273–82. 26 indexed citations
19.
Koyanagi, Satoru, et al.. (1981). Effects of dilazep on regional myocardial blood flow during selective coronary hypotension.. PubMed. 31(12). 2067–71. 3 indexed citations
20.
Lefer, Allan M., Shuichi Okamatsu, Edward F. Smith, & J. Bryan Smith. (1981). Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death. Thrombosis Research. 23(3). 265–273. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuhiro Yokota Breakdown of academic impact, for papers by Phillip Apprill Breakdown of academic impact, for papers by Ken Kanamasa Breakdown of academic impact, for papers by F Rauscha Breakdown of academic impact, for papers by Lüscher Tf Breakdown of academic impact, for papers by Alfonso Antonio Taccardi Breakdown of academic impact, for papers by James M. Schmitz Breakdown of academic impact, for papers by Pietro Paolo Campa Breakdown of academic impact, for papers by B Haider Breakdown of academic impact, for papers by Norio Fujita
Rankless by CCL
2026